Companies
Cyberkinetics
Cyberkinetics is a leader in the development of brain-computer interfaces with more than ten years of success in commercializing products for neuroscience research. Today, we bring together advances in neuroscience, computer science and engineering to develop products for emerging neurotechnology markets.
With a focus on individuals who have severe motor disabilities, Cyberkinetics is specifically applying its technology to the development of safe and effective systems to provide novel communication interfaces, the ability to control their environment and the potential to one day regain limb movement.
|
|
Oxford BioMedica
Oxford BioMedica is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.
Oxford BioMedica’s products use genes as the mediators of a therapeutic effect and/or immune response. The Company’s gene therapy products deliver therapeutic molecules in vivo whilst its gene-based immunotherapy products deliver genes that recruit the patient’s immune system to mediate a therapeutic effect. The genes are delivered by the Company’s highly engineered viral systems.
|
|
Saneron CCEL Therapeutics, Inc.
Saneron CCEL Therapeutics, Inc. is an entrepreneurial, biotechnology R&D startup company; focused on neurological cell-therapy for the early intervention and treatment of neurodegenerative disorders.
|
|
CytRx Corporation
CytRx is a world leader in developing products based on advanced RNAi technology primarily for the human health care market. RNAi has been shown to effectively silence a targeted disease-causing gene within a living cell. The technology essentially uses ribonucleic acid to selectively turn off the harmful genes of infectious viruses or malignant tumor cells. CytRx has a broad based strategic alliance with the University of Massachusetts Medical School (UMMS) which has given the company unparalleled access to RNAi technology and serves as a broad platform for a myriad of drug discovery applications including obesity, type 2 diabetes, ALS (Lou Gehrig’s disease), and CMV (cytomegalovirus).
|
|
Power3 Medical Products, Inc.
Power3 Medical is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.
|
|
Actions
Category Stats
Listings: 5
Regular: 5
Last listing added: 08/01/05
Details
Rate
Report
Comments (0)